Promoting sustainable national action to tackle antimicrobial resistance: a proposal to develop an antimicrobial resistance accountability index

  26 September 2024

Antimicrobial resistance (AMR) is a significant public health crisis, causing 1-14 million deaths worldwide in 2021. If not addressed, AMR could cost the global economy $412 billion annually due to increased healthcare costs and $443 billion annually due to lost workforce productivity. Despite progress, countries are inconsistent in implementing recommended policies, such as stewardship of antimicrobials, infection prevention, public awareness, and investment in research and development of novel antimicrobials and alternatives. Factors influencing global inconsistency include differences in resources, political commitment, healthcare infrastructure, and public health priorities. Additionally, many countries lack accountability mechanisms, leading to weak governance mechanisms and high AMR rates. Policymakers and academics are calling for a target-based approach to stimulate consistent implementation of AMR policies globally. The 2024 UN political declaration includes targets to achieve by 2030, including a 10% reduction in mortality from bacterial AMR, 70% reduction in access group antibiotics, and a funded AMR national action plan.

Further reading: The Lancet Microbe
Author(s): Michael Anderson et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed